Appili Therapeutics Inc. (APLIF)

USD 0.03

(0.0%)

Revenue Summary of Appili Therapeutics Inc.

  • Appili Therapeutics Inc.'s latest annual revenue in 2024 was 827.4 Thousand CAD , down -40.5% from previous year.
  • Appili Therapeutics Inc.'s latest quarterly revenue in 2024 FY was 827.4 Thousand CAD , down -40.5% from previous quarter.
  • Appili Therapeutics Inc. reported a annual revenue of 1.39 Million CAD in annual revenue 2023, down 0.0% from previous year.
  • Appili Therapeutics Inc. reported a annual revenue of 1.39 Million CAD in annual revenue 2022, down 0.0% from previous year.
  • Appili Therapeutics Inc. reported a quarterly revenue of 827.4 Thousand CAD for 2024 FY, down -40.5% from previous quarter.
  • Appili Therapeutics Inc. reported a quarterly revenue of 478.39 Thousand CAD for 2024 Q3, up 41.83% from previous quarter.

Annual Revenue Chart of Appili Therapeutics Inc. (2024 - 2017)

Historical Annual Revenue of Appili Therapeutics Inc. (2024 - 2017)

Year Revenue Revenue Growth
2024 827.4 Thousand CAD -40.5%
2023 1.39 Million CAD 0.0%
2022 1.39 Million CAD 0.0%
2021 - CAD -100.0%
2020 199.1 Thousand CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%

Peer Revenue Comparison of Appili Therapeutics Inc.

Name Revenue Revenue Difference
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 94.754%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -4595.573%
SQZ Biotechnologies Company 21.47 Million USD 96.148%
Evofem Biosciences, Inc. 18.21 Million USD 95.458%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.327%
Mesoblast Limited 5.9 Million USD 85.981%
Propanc Biopharma, Inc. - USD -Infinity%
Genus plc 668.8 Million USD 99.876%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -101.725%
Marizyme, Inc. 645.81 Thousand USD -28.119%
ContraFect Corporation - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -977.9%
Intellipharmaceutics International Inc. 65.72 Thousand USD -1158.835%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -1993.747%
MultiCell Technologies, Inc. 49.32 USD -1677529.765%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 98.336%
EV Biologics, Inc. 48.9 Thousand USD -1592.039%
Q BioMed Inc. 284.35 Thousand USD -190.98%
Emmaus Life Sciences, Inc. 29.59 Million USD 97.204%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.663%
Oncotelic Therapeutics, Inc. 70 Thousand USD -1082.01%
Skye Bioscience, Inc. - USD -Infinity%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -735.815%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -992.662%
IMV Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD -25.65%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.994%
Halberd Corporation 999.00 USD -82723.524%
Enzolytics Inc. 52.79 Thousand USD -1467.177%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 39.561%
SYBLEU INC 11.69 Thousand USD -6974.273%
Nuo Therapeutics, Inc. 608.52 Thousand USD -35.969%
argenx SE 1.22 Billion USD 99.933%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 57.174%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD -34.018%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.901%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.43%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD -48.358%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 17.071%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 98.289%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 16.68 Million USD 95.041%
ONE Bio Corp. 52.29 Million USD 98.418%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -249.766%
Regen BioPharma, Inc. 236.56 Thousand USD -249.766%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -489.985%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -74.658%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 89.377%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -6264.669%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -1992.9%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 75.153%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 87.586%
IntelGenx Technologies Corp. 1.03 Million USD 20.365%
Gelesis Holdings, Inc. 25.76 Million USD 96.789%
CSL Limited 14.8 Billion USD 99.994%
Cellectis S.A. 755 Thousand USD -9.59%